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Abstract
It was previously shown in model systems that brain spectrin binds membrane phospholipids. In the present study, we analysed binding of
isolated brain spectrin and red blood cell spectrin to red blood or neuronal membranes which had been treated as follows: (1) extracted with
low ionic-strength solution, (2) the above membranes extracted with 0.1 M NaOH, and (3) membranes treated as above, followed by protease
treatment and re-extraction with 0.1 M NaOH. It was found that isolated, NaOH-extracted, protease-treated neuronal and red blood cell
membranes bind brain and red blood cell spectrin with moderate affinities similar to those obtained in model phospholipid membrane–
spectrin interaction experiments. Moreover, this binding was competitively inhibited by liposomes prepared from membrane lipids. The
presented results indicate the occurrence of receptor sites for spectrins that are extraction- and protease-resistant, therefore most probably of
lipidic nature, in native membranes.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
In red blood cells, spectrin is a major component of the
membrane skeleton, whereas in nonerythroid cells, spectrin
can be found not only in the plasma membrane, but also in
many other membranes, as well as in the cytosolic compart-
ment. This localization suggests that spectrin may be
involved in many cellular processes (for a review, see e.g.
Ref. [1]). For example, neuronal spectrin is thought to play
an essential role in Ca2 +-regulated exocytosis in the nerve
terminal and in neurotransmitter release [2].
Spectrin is usually a tetramer formed by head-to-head
interaction of two identical heterodimers formed by parallel
interactions of nonindentical a and h subunits. The spectrin
a-subunit is a polypeptide of a molecular weight of 280 kDa
[3], while the h subunit’s molecular weight is 274 kDa
(nonerythroid) [4] or 246 kDa (erythroid) [5].
It was previously shown by several laboratories [6–11]
that erythroid spectrin binds directly to liposomes, in
particular to these containing aminophospholipids: phos-
phatidylethanolamine (PE) and phosphatidylserine (PS).
The capability of interaction of red blood cell spectrin with
phospholipids was shown using numerous methods [8–13].
We also demonstrated that nonerythroid (brain) spectrin
exhibited an ability to bind to liposomes made from PC and
its mixture with PE and PS, as well as to liposomes prepared
from total brain membrane lipids. The affinities of brain
spectrin for liposomes prepared from these lipids were
rather high—the obtained equilibrium dissociation constant
(Kd) values were in the submicromolar range [14].
In spite of more than 25 years of studies of spectrin–
membrane lipid interactions, the question whether protein-
independent sites for spectrins could be demonstrated in
natural membranes still remained to be answered. One
possible experimental approach to explain this problem is
presented in this work. Namely, we show that brain and
erythrocyte spectrins are able to interact with natural mem-
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branes (synaptic plasma membrane and red blood cell
membrane) in which membrane protein receptors have been
extracted or destroyed by proteolysis. Extraction and pro-
tease treatment of membrane preparations was performed
according to Steiner and Bennett [15]. As a result, we have
observed a specific, saturable, high to moderate affinity
binding of brain and erythrocyte spectrins to membranes
deprived of proteins by the extraction with 0.1 M NaOH and
digestion with a-chymotrypsin and re-extraction with 0.1 M
NaOH, indicating that these kinds of receptor sites are
present in natural membranes. Lipidic nature of these sites
is confirmed by competitive inhibition of binding by artifi-
cial vesicles prepared from membrane lipids.
2. Materials and methods
2.1. Materials
Sephacryl S-500 HR, DEAE-Sephacel, Sepharose 4B,
EGTA, phenylmethanesulfonyl fluoride (PMSF), and a-
chymotrypsin were from Sigma Chemical (St. Louis, MO,
USA). Dithiothreitol (DTT), coomassie brilliant blue R-250,
and EDTA were from Serva Feinbiochemica (Heidelberg,
Germany). SDS was from BDH Laboratory Supplies (Poole,
England). Dimethyl sulfoxide (DMSO) was from Merck
(Darmstadt, Germany). Tetramethylrhodamine-5-maleimide
single isomer (T-6027) was from Molecular Probes (Eugene,
OR, USA).
2.2. Methods
Brain spectrin was isolated from bovine brains according
to Bennett at al. [16]. Final preparations contained only
spectrin bands, of apparent molecular weights of 280 and
274 kDa, with traces of a proteolytic f 150 kDa fragment
of the a-spectrin subunit, as determined by SDS-(7%)-
polyacrylamide gel electrophoresis in the Laemmli [17]
system.
Erythrocyte spectrin was isolated from bovine red blood
cells by extraction of red blood cell ghosts with low ionic-
strength buffer at 37 jC, as was described previously [8].
Protein purified by Sepharose 4B column chromatography
contained only erythrocyte spectrin bands of apparent
molecular weights of 280 and 246 kDa, as analysed by
SDS-polyacrylamide gel electrophoresis.
Three types of neuronal membrane and red blood cell
membrane preparations were used in the study: the first
were neuronal membranes and erythrocyte membranes
remaining after extraction of spectrins with low ionic-
strength buffer (here referred to as untreated membranes).
The second type were the above membranes extracted with
10 volumes of 0.1 M NaOH for 30 min at 4 jC, as was
described by Steiner at al. [18]. The NaOH-extracted
membranes were layered over 10% sucrose in a 10-mM
HEPES buffer containing 1 mM EGTA, 1 mM NaN3, 1 mM
DTT, 50 Ag/ml PMSF, pH 7.5, and centrifuged at 17000 g
for 40 min. The resulting pellet of NaOH-extracted mem-
branes was washed with the HEPES buffer without sucrose
(17000 g for 30 min) and membranes were resuspended
in the same buffer without sucrose and PMSF. The third
type of membrane preparations was the above membranes
(NaOH treated) digested with TPCK-treated a-chymotryp-
sin (100 Ag/ml), as described by Steiner et al. [18], and then
re-extracted with 0.1 M NaOH and washed as described
above.
Brain and red blood cell membranes were analysed by
SDS-polyacrylamide gel electrophoresis performed on 3.5–
15% gradient gel with the buffers of the Laemmli [17]
system and were tested by Western blotting by using anti-
brain spectrin and anti-ankyrin antibodies obtained in our
laboratory. All the membrane preparations were finally
washed with an assay buffer consisting of 5 mM Tris, 0.5
mM EDTA, 150 mM NaCl, 0.5 mM DTT, 1 mM NaN3, at
pH 7.5. Purified bovine brain and erythrocyte spectrin
preparations were dialysed against the same assay buffer.
Two hundred and twenty microlitres of the incubation
mixture contained 22 Ag membrane protein and 0–100
nM purified spectrin (final concentration). After 30 min
incubation at room temperature (20 jC), 180 Al of the
sample was layered on a 300-Al cushion of 0.5% Dextran
T-40 in the assay buffer and centrifuged at 17000 g for 6
min. Resulting pellets were subjected to SDS-(7%)-poly-
acrylamide gel electrophoresis. Quantitation of bound spec-
trin in the pellets was performed by elution of coomassie
brilliant blue stain from the excised polyacrylamide gel
zones with DMSO, and measuring the absorbance at 595
nm, as described previously [14]. Spectrin for the experi-
ments showing the effect of heat treatment was incubated at
67 jC (brain spectrin) and at 58 jC (erythrocyte spectrin)
for 15 min before the assay, as was described by Steiner and
Bennett [15].
Liposomes were prepared from lipids extracted from
bovine brain synaptic plasma membranes [19,20] (for the
composition of the prepared ‘‘natural lipids’’—see Ref.
[14]). Hand-shaken liposomes were calibrated using 100
nm polycarbonate membranes (Nucleopore Track-Etch
Membrane PC MB 25 mm 1 UM, Whatman Nucleopore)
in a Mini-Extruder (PPH Marker, Poland). For sedimenta-
tion tests (described above), liposomes of a diameter of
100–160 nm (79%) according to the measurements taken
with ZetaSizer (Malvern Instruments, Malvern, UK) were
used. They did not produce sediment upon centrifugation at
17000 g.
For fluorescence experiments, purified brain and eryth-
rocyte spectrins were labelled with tetramethylrhodmine-5-
maleimide. Proteins were dialysed against the buffer: 5 mM
Na2HPO4, 50 mM NaCl, and 0.1 mM EGTA, pH 7.6, and
100 Al ethanolic solution of the tetramethyl-rhodamine-5-
maleimide (20 mg/ml) was added. After incubation for 2 h
in the dark, at room temperature, DTT was added to the
mixture (final concentration of 0.5 mM). Mixtures were
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dialysed overnight against the buffer described above for 2
days (three buffer changes).
For the competition, the assays were as follows: labelled
spectrins were incubated with a-chymotrypsin-digested and
NaOH-re-extracted synaptic plasma membranes in the pres-
ence of unlabelled spectrins at concentrations ranging from
0- to 30-fold excess over labelled proteins. Obtained pellets
were dissolved in 2 ml 1% SDS. Fluorescence measure-
ments were taken after 15 min at 545 nm (excitation wave-
length) and 567 nm (emission wavelength) in a Kontron
spectrofluorimeter at room temperature. In control experi-
ments, BSA instead of unlabelled spectrin was used.
3. Results
To find out whether natural membranes retain spectrin-
binding activity after removal of proteins by extraction with
NaOH and proteolysis, brain and erythrocyte membrane
preparations treated as in Refs. [15,18] were used. After
the extraction of neuronal membranes and erythrocyte ghosts
with 0.1 M NaOH, we observed the presence of only traces
of peripheral membrane proteins, mainly spectrin. The
digestion of NaOH-extracted membranes with a-chymotryp-
sin and the re-extraction with 0.1 M NaOH removed the
remaining spectrin, as well as other peripheral proteins, and
reduced the molecular masses of integral membrane proteins
[17] (Fig. 1). An example of the results of binding assay of
brain and erythrocyte spectrins to the a-chymotrypsin-
digested and NaOH re-extracted brain membranes is shown
in Fig. 2. In Western blot analysis, no traces of spectrin and
ankyrin were detected in a-chymotrypsin-digested and
NaOH-re-extracted brain and red blood cell membranes by
using anti-spectrin and anti-ankyrin antibodies (Fig. 3).
Fig. 4A shows the binding isotherms of purified brain
spectrin to spectrin-depleted synaptic plasma membranes at
pH 7.5. Increasing concentrations of purified brain spectrin
(6–42 nM) were incubated with synaptic membranes
remaining after the extraction of brain spectrin by incuba-
tion in low ionic-strength buffer. The same procedure was
repeated using NaOH-extracted and a-chymotrypsin-
digested, NaOH-re-extracted synaptic plasma membranes
(Fig. 4, Materials and methods). In all the cases, we
observed saturable binding of spectrin. The Kd values and
maximal binding capacities (Bmax) resulting from these
experiments are given in Table 1. The Kd values obtained
are in the nanomolar range, meaning that the affinities of
these interactions are rather high.
Fig. 1. Coomassie blue-stained SDS-(3.5–15%)-polyacrylamide gradient
gel electrophoretogram of the membrane preparations. Lanes A–D:
erythrocyte membranes; lanes E–G: synaptic plasma membranes; lane A:
red blood cell ghosts; lanes B and E: red blood cell and synaptic plasma
membranes, respectively, extracted with low ionic-strength solution at 37
jC (untreated membranes); lanes C and F: erythrocyte and synaptic plasma
membranes extracted with 100 mM NaOH for 30 min at 4 jC; lanes D and
G: the same membranes digested with TPCK-treated a-chymotrypsin
according to Steiner et al. [18]. Other details in Materials and methods.
Fifteen micrograms of membrane protein was applied on each lane.
Fig. 2. An example of SDS-(7%)-polyacrylamide gel electrophoretogram of the assay of binding spectrin to the a-chymotrypsin-digested and NaOH re-
extracted brain membranes. Lane 1: membranes only; lanes 2–6: brain spectrin at concentrations of 3.2, 4.8, 6.4, 8.0, and 9.6 Ag/assay; lanes 7–11: erythrocyte
spectrin at concentrations of 4.0, 6.0, 8.0, 10.0, and 12.0 Ag/assay. Lanes 12 and 13: brain and erythrocyte spectrin reference.
Fig. 3. Western blot analysis of brain (A, C) and erythrocyte (B, D)
membranes. Membrane proteins separated in SDS-gel electrophoresis were
transferred onto nitrocellulose membrane and probed with rabbit anti-
spectrin (A, B) and anti-ankyrin (C, D) serum. (1) Red blood cell ghosts; (2)
low ionic-strength extracted membranes; (3) the same, extracted with
NaOH; (4) a-chymotrypsin-digested and NaOH-re-extracted membranes.
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An interaction of brain spectrin with erythrocyte mem-
branes treated the same way as neuronal membranes was
also studied. Results shown in Fig. 4B indicate that isolated
brain spectrin binds to untreated, extracted with 0.1 M
NaOH as well as digested with a-chymotrypsin erythrocyte
membranes under the conditions identical to those presented
above, with regard to synaptic plasma membrane binding.
The Kd values obtained are also in the nanomolar range (see
Table 1), although 5- to 10-fold higher than in the case of
brain spectrin binding to neuronal membranes.
The results of the analysis of the interaction of eryth-
rocyte spectrin with erythrocyte membranes are shown in
Fig. 4C. They indicate that isolated erythrocyte spectrin
binds to untreated, extracted with 0.1 M NaOH, digested
with a-chymotrypsin erythrocyte in a similar way to that
shown for brain spectrin and neuronal membranes. These
interactions are characterised by Kd values in the nanomolar
range (see Table 1).
Our next goal was to examine whether erythrocyte
spectrin binds to the membranes from the brain. The
results of the experiments are shown in Fig. 4D and, as
can be seen in Table 1, the parameters of the binding
isotherms of erythrocyte spectrin attachment to neuronal
membranes are similar to those for brain spectrin and brain
membranes.
We posed a question whether heated spectrins bind to the
membrane similarly to the native protein. We tested the
interaction of brain spectrin with a-chymotrypsin-digested
and NaOH-re-extracted synaptic membranes. The results of
the experiments are shown in Fig. 5. The obtained binding
isotherms of brain spectrin to a-chymotrypsin-digested
membranes are saturable, indicating affinities in the nano-
molar range (39 nM). The binding isotherm of erythrocyte
spectrin to a-chymotrypsin-digested red blood cell mem-
branes is similar to those observed for brain spectrin
interaction (Fig. 5). This interaction is characterised by a
Kd of 22 nM.
Fig. 6 shows the results of inhibition of brain spectrin
interaction with brain membranes by exogenous phospholi-
pid liposomes. Increasing concentrations of small liposomes
prepared from ‘‘natural lipids’’ extracted from synaptic
membranes were incubated with untreated brain membranes
and constant concentrations of brain spectrin. The same
procedure was repeated using NaOH-extracted and a-chy-
motrypsin-digested neuronal membranes. Dixon [21] plot of
the results of inhibition curves indicated that liposomes
Fig. 4. Binding of the brain spectrin by synaptic plasma membranes (A), binding of the brain spectrin by red blood cell membranes (B), binding of the
erythrocyte spectrin by red blood cell membranes (C), and binding of the erythrocyte spectrin by synaptic plasma membranes (D). Increasing concentrations of
purified spectrin were incubated with membranes after extraction with low ionic-strength solution (.), NaOH-extracted membranes (o), and a-chymotrypsin-
digested and NaOH-re-extracted membranes (5). Other details in Materials and methods. Error bar = standard error.
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prepared from brain membranes competitively inhibited the
binding of brain spectrin to NaOH-extracted (Fig. 6B) and
a-chymotrypsin-digested (Fig. 6C) brain membranes. The
effect of liposomes on interaction of these last membranes
with spectrin was much larger when compared to that
observed for the interaction between brain spectrin and
untreated synaptic membranes (Fig. 6A).
Fig. 7 shows the results of inhibition of brain spectrin
labelled with tetramethylrhodamine-5-maleimide interaction
with a-chymotrypsin-digested and NaOH-re-extracted neu-
ronal membranes by unlabelled brain spectrin (Fig. 7A).
The molar ratio of the unlabelled to the labelled spectrin
varied from 1:1 to 5:1. A distinct inhibition was observed.
However, larger ratios at which plateau occurs were difficult
to obtain, because of the aggregation of brain spectrin at
concentrations higher than 200 Ag/ml.
Fig. 5. Binding of heated brain spectrin to a-chymotrypsin-treated synaptic
plasma membranes (o) and of heated erythrocyte spectrin to a-
chymotrypsin-treated red blood cell membranes (.). Increasing concen-
trations of purified spectrins were incubated with a-chymotrypsin-digested
and NaOH-re-extracted membranes. Other details in Materials and
methods.
Fig. 6. Inhibition of brain spectrin interaction with synaptic membranes by
liposomes prepared from natural membranes. Dixon [21] plot of the results
obtained for interaction of purified brain spectrin with synaptic membranes
after extraction with low ionic-strength solution (A), NaOH-extracted mem-
branes (B), and a-chymotrypsin-digested and NaOH-re-extracted mem-
branes (C). Brain spectrin concentration in the sample: 9 nM (.), 18 nM (o).
Table 1
Equilibrium dissociation constants (Kd) and maximal binding capacities
(Bmax) of the interaction of purified brain and erythrocyte spectrin with
‘‘natural’’ membranes from neural and erythrocyte cells
Interaction Membranes KdF S.E.
[nM]
BmaxF S.E.
[pmol/mg
membrane
protein]
Brain spectrin: Untreated 5.1F1.8 40.4F 2.9
synaptic plasma NaOH extracted 30.0F 11.6 51.6F 10.4
membranes Digested by
a-chymotrypsin
31.3F 12.1 49.4F 9.8
Brain spectrin: Untreated 45.2F 36.3 28.1F 9.6
erythrocyte NaOH extracted 76.1F 71.0 25.9F 12.0
membranes Digested by
a-chymotrypsin
209.8F 87.4 69.4F 21.0
RBC spectrin: Untreated 17.7F 2.9 144.9F 9.8
erythrocyte NaOH extracted 21.3F 3.7 112.5F 8.8
membranes Digested by
a-chymotrypsin
34.1F 8.3 129.7F 17.2
RBC spectrin: Untreated 14.3F 8.2 73.8F 14.7
synaptic plasma NaOH extracted 49.8F 24.0 74.3F 20.1
membranes Digested by
a-chymotrypsin
58.4F 9.8 96.9F 7.2
Data presented here were derived from the results of experiments shown in
Figs. 3–7 by using nonlinear regression. S.E. = standard error.
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The same procedure was repeated using erythrocyte
spectrin (Fig. 7B). The results were similar to those obtained
for the inhibition of interaction of the brain spectrin. The
molar ratio of the unlabelled to the labelled erythrocyte
spectrin varied from 1:1 to 30:1. Already at the molar ratio
of 1:1, a 20–30% inhibition of binding occurred. Maximal
inhibition, of approximately 60–70%, was observed at a
molar ratio of 10:1–30:1.
In control experiments, BSA instead of unlabelled spec-
trin was used (Fig. 7C). Even at a high weight ratio of 15:1
of BSA to spectrin, essentially no effect was observed.
4. Discussion
The aim of this study was to answer the question whether
spectrin-binding sites of lipidic nature do exist in natural
membranes. One of possible direct experimental approaches
was to isolate the membranes and remove or destroy known
protein receptors for spectrin by extraction and protease
treatment. The characteristics of the membranes extracted
with NaOH and digested with a-chymotrypsin were pre-
viously well documented by the studies of Steiner et al. [18].
Membranes prepared in this way were used by these and
other authors in several studies [15,22,23]. There is a small
probability that cannot be ruled out that some of integral
protein loops are protease-resistant; therefore, we should
talk about extraction and protease-resistant spectrin recep-
tors in the membrane.
Our data suggest that brain and erythrocyte spectrins bind
to ‘‘natural’’ membranes independently of the known protein
receptors. The affinities of these interactions are rather high,
characterised by Kd values in the nanomolar and submicro-
molar range. As was expected, the lowest Kd values were
observed in the case of membranes containing ankyrin, that
is, membranes extracted only with low ionic-strength sol-
ution. The second class of sites (also of proteinaceous nature)
which were well characterised by others [15,22,23] are the
so-called ankyrin-independent sites. These consist of two
subclasses: calcium-calmodulin-dependent and calcium-
independent spectrin-binding receptors located to the
amino-terminal and carboxyl-terminal regions of the non-
erythroid h-spectrin molecule, respectively [23]. These bind-
ing sites are formed by protein receptors not yet defined. The
affinities of the third class of spectrin receptors, that is,
protein-independent sites in the membrane, although the
smallest, are also in the nanomolar range (Table 1). The
Bmax values should be taken with caution, keeping in mind
that the amount of protein in the membrane is remarkably
lower in the case of membranes extracted with NaOH than in
the membranes extracted only with low ionic-strength sol-
ution, and the lowest concentration of protein was observed
in the case of protease-treated membranes. Why were these
lipidic sites not reported by others [22,23] studying the
binding of brain and erythrocyte spectrins to natural mem-
branes? One of the possible answers to this question seems to
be: the binding of spectrins, particularly brain spectrin, to
lipid domains of the membrane seems to be independent of
intact conformation of this protein [14]. This heat treatment-
Fig. 7. Inhibition of tetramethylrhodamine-5-maleimide-labelled brain (A)
and erythrocyte (B) spectrins (70 and 40 nM, respectively) interaction with
a-chymotrypsin-digested and NaOH-re-extracted synaptic membranes by
increasing concentrations of unlabelled brain spectrin (A) and erythrocyte
spectrin (B). The effect of BSA on binding of labelled brain spectrin (D)
and erythrocyte spectrin (.) is shown in C.
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resistant binding was treated by these authors as nonspecific.
Our data suggest that these sites are present in the native as
well in the heated brain and erythrocyte spectrins (at temper-
atures defined by others as abolishing membrane proteins-
binding capacity). The binding properties of the heated
spectrin seem to indicate specific binding, that is, a relatively
high affinity (Kd in the nanomolar range) and a relatively low
Bmax, comparable to those of the untreated membranes. This
is in accordance with our previous data [14] for spectrin–
phospholipid binding, in which brain spectrin was shown to
bind liposomes after heat denaturation as well as after
succinylation. The temperatures used for thermal treatment
of red blood cell spectrin (58 jC) and for brain spectrin (67
jC) [15] were reasonably higher than the major transition
temperatures (51 and 54 jC, respectively) [24]. It should be
noted, however, that both in the case of the brain and of the
erythrocyte spectrins, f 50% of the total residual ellipticity
was observed at the end of the transition, suggesting the
presence of an a-helical structure. The data of Brandts et al.
[25] indicate that even after heating to above 70 jC, more
than 30% of initial molar residue ellipticity was still
observed, suggesting the presence of a-helical structure
extremely resistant to thermal unfolding. Our spectrins
preparations heated to 58 and 67 jC retained 80% (eryth-
rocyte spectrin) and 70% (brain spectrin) of the initial molar
ellipticity after cooling on ice. When heating time was
increased to even 60 min, the residue ellipticity of the red
cell spectrin did not change while brain spectrin’s residue
ellpticity dropped to near 50% of the initial value (data not
shown). The differences with the data on the dependence of
the ellipticity on the temperature obtained by others [24,25]
are probably due to the fact that their spectra were taken upon
heating and ours were taken after cooling as suggested by
Steiner and Bennett [15]. Probably upon cooling, partial
refolding took place. These facts would explain the lipid-
binding activity of heat-treated spectrins and would be in
agreement with the previously published data on folding-
sensitive aminophospholipid vesicle binding by expressed
dystrophin fragments [26].
The affinities obtained for protease-treated membranes
are similar to those observed for the interaction of red blood
cell spectrin [9] and brain spectrin [14] with liposomes FAT
prepared from aminophospholipids and their mixtures.
Moreover, small liposomes prepared from lipids extracted
from demyelinated brain membranes seem to competitively
inhibit spectrin–membrane interactions. The lowest appa-
rent Ki value could be observed for the membrane prepara-
tion that had been extracted with NaOH and treated with a-
chymotrypsin.
Specificity of these interactions is also confirmed by
experiments in which fluorescently labelled erythroid and
brain spectrins were displaced by unlabelled proteins, while
high concentrations of bovine serum albumin, which was
used as nonspecific competitor, remained without effect.
Available data suggest that the PH domain of noneryth-
roid spectrin could be involved in its interaction with the
membrane [27–29]. A bacterially expressed N-terminal
segment of the hIA2 spectrin PH domain binds to crude
and extracted brain membranes, to protein-free brain lipids
and to vesicles containing phosphatidylinositol-4,5-bisphos-
phate [28]. This, however, is probably not the case here,
because recent structural studies [30,31] suggest that the
specificity of the pleckstrin homology domain is the phos-
phorylated inositol ring. In addition, data presented here
indicate that erythroid spectrin in which the PH domain is
missing binds protein-independent sites as well.
Our previous data [14] suggest that brain spectrin inter-
acts directly with membrane aminophospholipids which are
located on the cytoplasmic leaflet of the synaptosomal
membrane bilayer. In a monolayer study [32], it was shown
that the site for this interaction is located in the h subunit of
brain spectrin. It was previously found that erythrocyte
ankyrin inhibits the interaction of red blood cell spectrin
with phospholipid vesicles and monolayers [9]. This could
mean that the binding site for ankyrin and phospholipids
(mainly PE) may be, at least in part, overlapping. In the case
of nonerythroid (brain) spectrin, we also observed strong
inhibition of binding to a phospholipid monolayer by red
blood cell ankyrin [32].
Available data indicate that in synaptic plasma mem-
branes, there are at least several kinds of binding sites for
brain spectrin: our data suggest a relationship between the
ankyrin and the phospholipid (PE-containing) binding sites
[9,10,32]. The possible relationship between the above-
described protein-receptors-independent site(s) occurring
in natural membranes and so-called ankyrin-independent
binding of spectrin to the membranes remains to be eluci-
dated, but it requires identification of these receptors.
Aminophospholipid binding to spectrin in the erythro-
cyte membrane seems to be physiologically important, as
phospholipid asymmetry was shown to participate in stabi-
lisation of the mechanical properties of this cell [33].
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